Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial

Beauchet, Olivier; Barden, John; Liu-Ambrose, Teresa; Chester, Victoria L; Annweiler, Cedric; Szturm, Tony; Grenier, Sébastien; Léonard, Guillaume; Bherer, Louis; Allali, Gilles; Canadian Gait Consortium

doi:10.1007/s40266-016-0391-0

Scientific article

English

Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial

ContributorsBeauchet, Olivier; Barden, John; Liu-Ambrose, Teresa; Chester, Victoria L; Annweiler, Cedric; Szturm, Tony; Grenier, Sébastien; Léonard, Guillaume; Bherer, Louis; Allali, Gilles; Canadian Gait Consortium

Published inDrugs & Aging, vol. 33, no. 9, p. 665-673

Publication date2016

Abstract

Few studies have examined the effect of anti-dementia drugs (i.e., acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists) on gait performance. Past studies have focused on the stride time (i.e., gait cycle duration) but not on the mental imagery of gait.

Keywords

Aged
Aged
80 and over
Alzheimer Disease/drug therapy/physiopathology/psychology
Cholinesterase Inhibitors/administration & dosage/adverse effects/therapeutic use
Cohort Studies
Female
Gait/drug effects
Geriatric Assessment
Humans
Imagination/physiology
Male
Memantine/administration & dosage/adverse effects/therapeutic use
Receptors
N-Methyl-D-Aspartate/antagonists & inhibitors
Spatio-Temporal Analysis
Task Performance and Analysis
Walking/physiology/psychology

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques

Citation (ISO format)

BEAUCHET, Olivier et al. Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial. In: Drugs & Aging, 2016, vol. 33, n° 9, p. 665–673. doi: 10.1007/s40266-016-0391-0

Article (Published version)

Identifiers

PID : unige:99188
DOI : 10.1007/s40266-016-0391-0
PMID : 27568453

Journal ISSN1170-229X

461views

0downloads

Creation23/08/2017 13:56:00

First validation23/08/2017 13:56:00

Update15/03/2023 02:23:03

Status update15/03/2023 02:23:03

Last indexation31/10/2024 08:38:04

Archive ouverte UNIGE

Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial

Few studies have examined the effect of anti-dementia drugs (i.e., acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists) on gait performance. Past studies have focused on the stride time (i.e., gait cycle duration) but not on the mental imagery of gait.

Technical informations